Correction Open Access
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Jun 15, 2022; 14(6): 1216-1217
Published online Jun 15, 2022. doi: 10.4251/wjgo.v14.i6.1216
Correction to "MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation"
Yong-Shuang Li, Ying Zou, Dong-Qiu Dai, Department of Gastrointestinal Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang 110032, Liaoning Province, China
ORCID number: Yong-Shuang Li (0000-0002-0474-853X); Ying Zou (0000-0003-2067-0995); Dong-Qiu Dai (0000-0002-1154-3276).
Author contributions: Li YS and Dai DQ submitted the final manuscript and all authors read and approved the final version.
Conflict-of-interest statement: All authors declare that they have no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Dong-Qiu Dai, MD, PhD, Chief Doctor, Professor, Surgical Oncologist, Department of Gastrointestinal Surgery, The Fourth Affiliated Hospital of China Medical University, No. 4 Chongshan East Road, Shenyang 110032, Liaoning Province, China. daidq63@163.com
Received: October 25, 2021
Peer-review started: October 25, 2021
First decision: April 17, 2022
Revised: April 19, 2022
Accepted: April 22, 2022
Article in press: April 22, 2022
Published online: June 15, 2022

Abstract

We rechecked the original data of Figure 3, Part.B, and found that 0 h group in the BGC-823 cell wound scratch assay was misapplied. Therefore, we are writing to apply for the modification of Figure 3, Part.B.

Key Words: Correction, Gastric cancer, miRNA-320a, DNA methylation

Core Tip: This is a correction to "MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation".
CORRECTION

Correction to: Li YS, Zou Y, Dai DQ. MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation. World J Gastrointest Oncol 2019; 11(10): 842-856 PMID: 31662823 DOI: 10.4251/wjgo.v11.i10.842.

We recently read our manuscript published in the World Journal of Gastrointestinal Oncology (Manuscript NO: 48527, DOI: 10.4251/wjgo.v11.i10.842), we have carefully rechecked the original data of Figure 3, Part.B, and found that 0 h group in the BGC-823 cell wound scratch assay was misapplied. Therefore, we are writing to apply for the modification of Figure 3, Part.B. The revised images are shown in this Correction (Figure 1). We feel deeply sorry for this mistake during the proofreading process. This correction does not alter any interpretation of the results or conclusion of this study[1].

Figure 1
Open in New Tab   Full Size Figure   Download Figure
Figure 1 Part.B. Overexpression of miR-320a suppressed gastric cancer cell migration and invasion.

We apologize for any inconvenience caused by this mistake.

Footnotes

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Oncology

Country/Territory of origin: China

Peer-review report’s scientific quality classification

Grade A (Excellent): 0

Grade B (Very good): B, B

Grade C (Good): C

Grade D (Fair): 0

Grade E (Poor): 0

P-Reviewer: Hori T, Japan; Kapritsou M, Greece; Moshref L, Saudi Arabia S-Editor: Wang LL L-Editor: A P-Editor: Wang LL

References
1.  Li YS, Zou Y, Dai DQ. MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation. World J Gastrointest Oncol. 2019;11:842-856.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 15]  [Cited by in F6Publishing: 15]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]